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Dear Sir,
Surgical protocols were introduced by the Adult Burn Service, Royal Adelaide Hos-
pital, in early 2005,1 documenting both instructions and techniques. Underlying these
protocols is the need for expeditious burn excision. Where lower airway inhalation injury
coexists, there appears to be a “surgical window” that opens at the time of the burn injury
and closes 48 to 72 hours later. Although resuscitation is ongoing, the respiratory tract
appears robust to early surgery. Following resuscitation, in patients with inhalation injury,
the respiratory tract “goes off” as chemical pneumonitis and adult respiratory distress syn-
drome develop around the 48- to 72-hour point. If burn remains at this stage, the patient
is often too unwell for aggressive surgery. By the time the respiratory tract has recovered
sufﬁciently,retainedburn escharstartsdegradingand isbacteriallycontaminated.Systemic
problems,especiallyrenal,ensue.Inotropemedicationismostlikelytobenecessaryduring
this time. This has the potential (at doses > 30 μg/min noradrenaline) to convert superﬁcial
burns and donor sites to full-thickness injuries and critically impair the developing blood
supply to skin grafts and Integra, resulting in loss.
The burns to be excised and proposed donor sites are tumesced subcutaneously with
a solution of 1:500,000 adrenaline in 0.9% saline. Blood transfusion is uncommon and
excisionsofmorethan80%totalbodysurfacearea(TBSA)canbeperformedonadmission.
This is in keeping with published literature.2
The protocols have proved invaluable. As stepwise instructional aids for new regis-
trarsinvolvedinburn careon-callandpreparationforspecialistexaminations,nopublished
alternative exists. Other units have used them as templates for their own protocol develop-
ment.
They have allowed considered evaluation of new techniques and dressings against
an established “gold standard” of treatment enabling accurate comparison. They have
safeguardedtheuseofexpensivematerials(eg,Integra),incorporatedintowell-constructed
and transparent algorithms, from administrative and budgetary scrutiny.
Some changes have been necessary (and anticipated) in the past 4 years. Transcyte
was our primary face burn dressing in burns greater than 20% TBSA; this material is now
(sadly)unavailable.FacecareontheBurnUnitcanbemanagedsimplywithsoftparafﬁnand
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meticulous care, but in ICU, the siting of the endotracheal and nasogastric/feeding tubes,
with intraoral and airway burns, leads to ﬂuid leakage from nares and oral commissures,
risking infection of facial burns. Aquacel Ag, a silver-impregnatedalginate,adheres well to
facial exudate needing no ﬁxation. It can be easily removed/refreshed and easily fashioned
into a face mask.
The Skin Engineering Laboratory previously supplied a noncultured suspension of
keratinocytes and melanocytes, analogous to C3’s Re-CellTM, to hasten re-epithelialization
of donor sites and meshed split-skin graft interstices. However, a randomized, placebo-
controlled trial failed to show any ability to expedite reepithelialization,3 forcing removal
from use.
The failure of both Victorian and New Zealand Cadaver Skin banks to reliably provide
allograft for patients with major burn injury led to its removal from the protocols. Biobrane
works just as well in temporizing the debrided burn wound.4
Protocoldevelopmenthasthusbeenworthwhileonmanylevels;however,regularaudit
must follow and changes are inevitable. They remain available to anyone on application.
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